BCR/ABL 210 kD fusion protein 259-269 (HLA-A*03:01) (HLA-A*11:01)

BCR/ABL 210 kD fusion protein 259-269 (HLA-A*03:01) (HLA-A*11:01)
Buy 5, pay 4 If you order 5 or more of the same off-the-shelf peptide product at once, you will receive one of them for free.
€60.40 *

Prices plus VAT plus shipping costs

Delivery time 3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.

Amount in mg:

5 mg

  • Order number: EP11088_1
Description Technical data Documents Accessories
Description
This peptide has high avidity for CD8 T cells, and can be used in the analysis of individual... more
Close menu
Product information "BCR/ABL 210 kD fusion protein 259-269 (HLA-A*03:01) (HLA-A*11:01)"

This peptide has high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide composed BCR-ABL 210 kD fusion protein-derived peptide of ATGFKQSSK sequence covering 259-269 and A*03:01, A*11:01 molecule.

Available downloads:
more

Zurück
 
Sequence:ATGFKQSSK
Gene:BCR
Delivery: 3 weeks
C-Terminus:OH
N-Terminus:H
Purity:95%
Amount:1 mg
Counter Ion:TFA
Protein:Human Bcr-abl 210 kD fusion protein
Species:Human
Allele:HLA-A*03:01 HLA-A*11:01
Application :Flow Cytometry
Indication :Cancer
####
    Dokumente - Protokolle - Downloads more
    Zurück

    Protocols and Tips

    Data sheets

     
    Accessories 0
    Viewed
    This website uses cookies to ensure you get the best experience on our website.
    Accept
    BCR/ABL 210 kD fusion protein 259-269 (HLA-A*03:01) (HLA-A*11:01)